Androgenetic alopecia – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 10:30:36 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Androgenetic alopecia – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on the Effectiveness and Safety of Clascoterone Solution for Treating Male Pattern Hair Loss https://clinicaltrials.eu/trial/study-on-the-effectiveness-and-safety-of-clascoterone-solution-for-treating-male-pattern-hair-loss/ Wed, 29 Apr 2026 14:26:22 +0000 https://clinicaltrials.eu/trial/study-on-the-effectiveness-and-safety-of-clascoterone-solution-for-treating-male-pattern-hair-loss/ This clinical trial is focused on studying Androgenetic Alopecia, commonly known as male pattern hair loss. The treatment being tested is a topical solution called Clascoterone, also known by its code name CB-03-01. This solution is applied directly to the skin and is designed to help with hair loss in men.

The purpose of the study is to evaluate how effective and safe the Clascoterone solution is in treating male pattern hair loss. The study will last for a total of 12 months. During the first 6 months, participants will be randomly assigned to use either the Clascoterone solution or a vehicle solution, which does not contain the active ingredient. This part of the study is double-blind, meaning neither the participants nor the researchers know who is receiving which treatment. After this period, all participants will use the Clascoterone solution for another 6 months in a single-blind phase, where only the researchers know the treatment details.

Participants will apply the solution twice a day and will be monitored for changes in hair growth and any side effects. The study aims to provide insights into the potential benefits of Clascoterone for men experiencing hair loss.

]]> Study on the Effectiveness and Safety of Oral Minoxidil for Women with Androgenetic Alopecia https://clinicaltrials.eu/trial/study-on-the-effectiveness-and-safety-of-oral-minoxidil-for-women-with-androgenetic-alopecia/ Wed, 29 Apr 2026 14:25:20 +0000 https://clinicaltrials.eu/trial/study-on-the-effectiveness-and-safety-of-oral-minoxidil-for-women-with-androgenetic-alopecia/ This clinical trial is focused on studying the effects of a medication called Minoxidil on women experiencing a type of hair loss known as female androgenetic alopecia, which is often related to hormonal imbalances. The study will compare the effectiveness and safety of taking Minoxidil in a 1 mg tablet form, taken orally once a day, against a placebo, which is a substance with no active medication. Additionally, the study will involve a topical solution, which is applied directly to the skin, to further assess the treatment’s impact on hair growth.

The purpose of the study is to determine if the oral Minoxidil treatment is as effective as the control treatment, which includes a placebo tablet and a topical solution containing 2% Minoxidil. Participants will be randomly assigned to different groups to receive either the active treatment or the placebo. The study will last for about six months, during which participants will have regular check-ups to monitor changes in hair growth and overall health. The main focus will be on the change in the number of non-vellus hairs, which are thicker and more visible, in a specific target area of the scalp.

Throughout the study, participants will be asked to maintain their usual hair care routines and will be monitored for any side effects or changes in their health. The study aims to provide valuable information on the potential benefits of Minoxidil for women with hormone-related hair loss, helping to improve treatment options for this condition.

]]>